Evidence map›Paper›PMID 31998511›Full record

ArticleClinical case reports2020

Successful treatment of a case with NUT midline carcinoma in the larynx and review of the literature.

Hai Zhang, Ming-Hua Liu, Jie Zhang, Shu-Peng Luo, Chao-Bo Wang, Zeng-Hu Zhao, Yan-Li Ge, Jian-Yu Zhang, Feng-Hao Geng

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Head and neck NUT carcinoma-radiotherapy dose, chemotherapy choice, and outcomes: lessons from a 7-year complete remission.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hai ZhangDepartment of Oncology The Hospital of 81st Group Army PLA Zhang Jia Kou China.
Ming-Hua LiuDepartment of Pharmacy The Hospital of 81st Group Army PLA Zhang Jia Kou China.
Jie ZhangDepartment of Radiation Medicine Faculty of Preventive Medicine Air Force Medical University Xi'an China.
Shu-Peng LuoDepartment of Oncology The Hospital of 81st Group Army PLA Zhang Jia Kou China.
Chao-Bo WangDepartment of Oncology The Hospital of 81st Group Army PLA Zhang Jia Kou China.
Zeng-Hu ZhaoDepartment of Oncology The Hospital of 81st Group Army PLA Zhang Jia Kou China.
Yan-Li GeDepartment of Oncology The Hospital of 81st Group Army PLA Zhang Jia Kou China.
Jian-Yu ZhangDepartment of Oncology The Hospital of 81st Group Army PLA Zhang Jia Kou China.
Feng-Hao GengDepartment of Oncology The Hospital of 81st Group Army PLA Zhang Jia Kou China.ORCID https://orcid.org/0000-0002-0559-3701
82th Hospital of Pla · CNAir Force Engineering University · CNThe Fourth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this report, we gave the first case of successful treatment for laryngeal NMC, which is exceedingly rare with dismal prognosis. intensity-modulated radiation therapy accompanied by traditional Chinese medicine was administrated for the young woman, instead of radical resection, and she got continuous remission for more than 2 years, with no recurrence detected.

Indexed as

intensity‐modulated radiation therapylarynxNUT midline carcinomasuccessful treatmenttraditional Chinese medicine

Identifiers

PMID31998511
PMCPMC6982469
OpenAlexW2989836981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.